Business Wire | Oct 20, 2021 04:05PM EDT

Sage Therapeutics to Report Third Quarter 2021 Financial Results on Tuesday, November 2, 2021

Oct. 20, 2021

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 20, 2021--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Tuesday, November 2, 2021 at 8:00 a.m. ET to announce third quarter 2021 financial results and discuss recent business updates.

The webcast can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211020005960/en/

CONTACT: Investor Contact Helen Rubinstein 315-382-3979 helen.rubinstein@sagerx.com

CONTACT: Media Contact Maureen L. Suda 617-949-4289 maureen.suda@sagerx.com